Comparison 14. Low molecular weight heparin (LMWH) versus LMWH plus acemetacin.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Pulmonary embolism	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Deep vein thrombosis	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3 Extension of superficial thrombophlebitis	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4 Pain reduction	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
5 Hyperaemia reduction	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
6 Tenderness reduction	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
7 Palpable cord reduction	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
8 Mortality	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9 Major bleeding	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
10 Minor bleeding	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
11 Adverse events	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected